Anti-CD22 CAR-T Cell Therapy Targeting B Cell Malignancies
Clinical trial NCT03262298 · UNKNOWN
Trial details
- NCT number
- NCT03262298
- Sponsor
- Affiliated Hospital to Academy of Military Medical Sciences
- Status
- UNKNOWN
- Phase
- Phase 1, Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2017-08-20
- Primary completion
- 2021-08-20
- Enrollment
- 20
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.